Company Description
Taro Pharmaceutical Inds (NYSE: TARO) is a publicly traded pharmaceutical preparation manufacturing company in the Manufacturing sector. The company has a market capitalization of $1.6B, ranking #2,517 among all listed U.S. companies by market cap.
TARO stock has declined 100.0% over the past year. Shares last traded at $42.97.
This page provides a comprehensive overview of TARO stock, including price data, latest news, SEC filings, insider trading activity, financial highlights, upcoming events, and short interest trends.
Stock Performance
Taro Pharmaceutical Inds (TARO) stock last traded at $42.97. Over the past 12 months, the stock has lost 100.0%. At a market capitalization of $1.6B, TARO is classified as a small-cap stock with approximately 37.6M shares outstanding.
TARO Rankings
Latest News
Taro Pharmaceutical Inds has 10 recent news articles. Of the recent coverage, 4 articles coincided with positive price movement and 6 with negative movement. Key topics include acquisition, earnings. View all TARO news →
SEC Filings
Financial Highlights
Upcoming Events
Short Interest History
Days to Cover History
TARO Company Profile & Sector Positioning
Taro Pharmaceutical Inds (TARO) operates in the Pharmaceutical Preparation Manufacturing industry within the broader Manufacturing sector and is listed on the NYSE.